Enhancing Cardiovascular Disease Classification with Routine Blood Tests Using an Explainable AI Approach

Background: While machine learning (ML) is widely applied in cardiology, a critical research gap persists. The incremental diagnostic value of routine blood tests for classifying cardiovascular disease (CVD) remains largely unquantified, and many models operate as non-interpretable “black boxes,” limiting their clinical adoption. This study aims to address these gaps by quantifying the contribution of readily available laboratory panels and demonstrating the utility of transparent diagnostic modeling within a real-world clinical cohort. Methods: We conducted a retrospective study on the clinical data of 896 adult patients from a hospital database. A baseline feature set (demographics, vital signs) was compared against an enhanced set that additionally included results from routine hematology and biochemistry panels. Five machine learning classifiers were trained and evaluated. To ensure transparency, SHAP (SHapley Additive exPlanations) analysis, a key component of explainable AI (XAI), was used to interpret the predictions of the top-performing model. Results: The inclusion of routine blood tests consistently and significantly improved the performance of all classifiers. The XGBoost model demonstrated the best performance (accuracy 91.62%, precision 95.00%, recall 87.36%). Critically, SHAP analysis identified aspartate aminotransferase (AST), glucose, and creatinine as the most significant biomarkers, providing clear, interpretable insights into the biochemical drivers of the model’s predictions. Conclusion: Routine laboratory markers contain a strong, interpretable signal indicative of CVD that is crucial for accurate risk stratification. These findings underscore the diagnostic relevance of common blood biomarkers and demonstrate how explainable AI can transform routine clinical data into transparent and actionable cardiovascular insights. Further validation in larger and demographically diverse cohorts is warranted.

Authors

Institutions

Publication Details

Journal
Algorithms
Published
2025-11-07
DOI
https://doi.org/10.3390/a18110708
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhancing Cardiovascular Disease Classification with Routine Blood Tests Using an Explainable AI Approach

Sarsenbek Zhussupbekov, Assiya Boltaboyeva, Naoya Maeda-Nishino, Баглан Иманбек et al.
Algorithms
Artificial Intelligence in Healthcare and Education
article

Enhancing Cardiovascular Disease Classification with Routine Blood Tests Using an Explainable AI Approach

Sarsenbek Zhussupbekov, Assiya Boltaboyeva, Naoya Maeda-Nishino, Баглан Иманбек, Nurdaulet Tasmurzayev, Zhanel Baigarayeva, Bibars Amangeldy, Aliya Baidauletova
article en

Abstract

Background: While machine learning (ML) is widely applied in cardiology, a critical research gap persists. The incremental diagnostic value of routine blood tests for classifying cardiovascular disease (CVD) remains largely unquantified, and many models operate as non-interpretable “black boxes,” limiting their clinical adoption. This study aims to address these gaps by quantifying the contribution of readily available laboratory panels and demonstrating the utility of transparent diagnostic modeling within a real-world clinical cohort. Methods: We conducted a retrospective study on the clinical data of 896 adult patients from a hospital database. A baseline feature set (demographics, vital signs) was compared against an enhanced set that additionally included results from routine hematology and biochemistry panels. Five machine learning classifiers were trained and evaluated. To ensure transparency, SHAP (SHapley Additive exPlanations) analysis, a key component of explainable AI (XAI), was used to interpret the predictions of the top-performing model. Results: The inclusion of routine blood tests consistently and significantly improved the performance of all classifiers. The XGBoost model demonstrated the best performance (accuracy 91.62%, precision 95.00%, recall 87.36%). Critically, SHAP analysis identified aspartate aminotransferase (AST), glucose, and creatinine as the most significant biomarkers, providing clear, interpretable insights into the biochemical drivers of the model’s predictions. Conclusion: Routine laboratory markers contain a strong, interpretable signal indicative of CVD that is crucial for accurate risk stratification. These findings underscore the diagnostic relevance of common blood biomarkers and demonstrate how explainable AI can transform routine clinical data into transparent and actionable cardiovascular insights. Further validation in larger and demographically diverse cohorts is warranted.

AlgorithmsVol. 18(11)
Almaty Management University (KZ), Al-Farabi Kazakh National University (KZ), Kazakh Institute of Oncology and Radiology (KZ), Independent Expert Consulting Board to Promote Scientific Research Activity in Kazakhstan (KZ), Kishokai Medical Corporation (JP), Stanford University (US)
Openalex Percentile: Top 74%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.